Literature DB >> 11309648

Thyroid hormone and the d-type cyclins interact in regulating enterocyte gene transcription.

S Meng1, J Badrinarain, E Sibley, R Fang, R Hodin.   

Abstract

Thyroid hormone (T3) is an important regulator of gut mucosal development and differentiation, inducing intestinal alkaline phosphatase (IAP) and repressing lactase gene transcription. In contrast, cyclin D1 (CD1) appears to be a growth promoter in the gut, functioning to maintain the undifferentiated state. The present studies were designed to examine the effects of CD1 on T3 action within intestinal epithelia. Caco-2 cells were maintained in hypothyroid medium and transiently transfected with either rat lactase (3.0 kb) or human IAP (2.4 kb) luciferase (Luc) reporter plasmids. Cotransfections were carried out using two T3 receptor (TR) isoforms, TR"-1 and TR$-1, as well as plasmids expressing CD1, CD3, CA, or CB1. Cells were then treated +/- 10 nmol/L T3 for 24 hours and luciferase activity was determined. With T3 treatment, IAP-Luc activity was induced (TR"-1 = eightfold, TR$-1 = ninefold), but these effects were dramatically inhibited (> 50%) by CD1 and CD3. In contrast, CA and CB1 did not alter T3-mediated IAP gene activation. The ability of CD1 and CD3 to inhibit T3 action was also tested in the context of the lactase gene, which is negatively regulated by T3. As expected, lactase reporter gene activity was repressed by T3 treatment in the case of both receptor isoforms, TR"-1 = 30% and TR$-1 = 40%. In contrast to its effects on the IAP gene, CD1 did not inhibit T3-mediated changes in lactase reporter gene activity. The D-type cyclins (CD1 and CD3), but not CA or CB1, specifically inhibit T3-mediated activation of the IAP gene. In contrast, the D-type cyclins do not inhibit T3-mediated repression of the lactase gene. These studies have identified a novel molecular interaction that exists between the pathways of growth and differentiation within intestinal epithelia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309648     DOI: 10.1016/s1091-255x(01)80013-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  32 in total

1.  D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability.

Authors:  K E Knudsen; W K Cavenee; K C Arden
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

Review 2.  Progression through the cell cycle: an overview.

Authors:  J L Fridovich-Keil; L J Hansen; K Keyomarsi; A B Pardee
Journal:  Am Rev Respir Dis       Date:  1990-12

3.  The homeodomain protein Cdx2 regulates lactase gene promoter activity during enterocyte differentiation.

Authors:  R Fang; N A Santiago; L C Olds; E Sibley
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

4.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

Authors:  O Tetsu; F McCormick
Journal:  Nature       Date:  1999-04-01       Impact factor: 49.962

Review 5.  Thyroid hormone receptors: multiple forms, multiple possibilities.

Authors:  M A Lazar
Journal:  Endocr Rev       Date:  1993-04       Impact factor: 19.871

6.  Structural and functional maturation of rat gastrointestinal barrier with thyroxine.

Authors:  E J Israel; K Y Pang; P R Harmatz; W A Walker
Journal:  Am J Physiol       Date:  1987-06

7.  Thyroid hormone responsiveness is developmentally regulated in the rat small intestine: a possible role for the alpha-2 receptor variant.

Authors:  R A Hodin; S Meng; S M Chamberlain
Journal:  Endocrinology       Date:  1994-08       Impact factor: 4.736

8.  Secretion and distribution of rat intestinal surfactant-like particles after fat feeding.

Authors:  F Yamagishi; T Komoda; D H Alpers
Journal:  Am J Physiol       Date:  1994-05

9.  Thyroid hormone differentially regulates rat intestinal brush border enzyme gene expression.

Authors:  R A Hodin; S M Chamberlain; M P Upton
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

10.  Reversible lactose malabsorption and intolerance in Graves' disease.

Authors:  A Szilagyi; S Lerman; R G Barr; J Stern; A Colacone; S McMullan
Journal:  Clin Invest Med       Date:  1991-06       Impact factor: 0.825

View more
  6 in total

1.  The Composition of Gut Microbiota in Patients Bearing Hashimoto's Thyroiditis with Euthyroidism and Hypothyroidism.

Authors:  Simo Liu; Yaxin An; Bin Cao; Rongxin Sun; Jing Ke; Dong Zhao
Journal:  Int J Endocrinol       Date:  2020-11-10       Impact factor: 3.257

2.  Consequences of adrenalectomy on small intestine trophic parameters in aged and young rats: evidence of defective adaptation by aging and lack of corticoids.

Authors:  Benoit Foligne; Francoise Senegas-Balas; Raffaele Cursio; Chantal Cayuela; Jean-Michel Antoine; Nathalie Rolf-Petersen; Daniel Balas
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

Review 3.  Gut microbiota and Hashimoto's thyroiditis.

Authors:  Camilla Virili; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga; Marco Centanni
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

4.  Intestinal microbiota changes in Graves' disease: a prospective clinical study.

Authors:  Hui-Xian Yan; Wen-Cheng An; Fang Chen; Bo An; Yue Pan; Jing Jin; Xue-Pei Xia; Zhi-Jun Cui; Lin Jiang; Shu-Jing Zhou; Hong-Xin Jin; Xiao-Hong Ou; Wei Huang; Tian-Pei Hong; Zhao-Hui Lyu
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

5.  Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis.

Authors:  Leonardo César de Freitas Cayres; Larissa Vedovato Vilela de Salis; Guilherme Siqueira Pardo Rodrigues; André van Helvoort Lengert; Ana Paula Custódio Biondi; Larissa Donadel Barreto Sargentini; João Luiz Brisotti; Eleni Gomes; Gislane Lelis Vilela de Oliveira
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

6.  Simulation Model for Hashimoto Autoimmune Thyroiditis Disease.

Authors:  Marcela Salazar-Viedma; Juan Gabriel Vergaño-Salazar; Luis Pastenes; Vivian D'Afonseca
Journal:  Endocrinology       Date:  2021-12-01       Impact factor: 4.736

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.